Whole Person Healing.
For All.

Sunstone is redefining what it means to heal by creating a safe and compassionate setting for the delivery of psychedelic-assisted therapy within a medical framework. With a range of clinical trials, a highly-trained interdisciplinary team, and purposely designed centers, we are committed to treating the whole person.
Explore Our Clinical Trials

Pioneering a New Era
in Modern Medicine

Sunstone Therapies is a leader in the delivery of psychedelic-assisted therapy in the medical setting, focusing on clinical trials and future clinical delivery upon approval.
Psychedelic-Assisted Therapy
Clinical Trials
Published Research
Patient Experience
Centers for Healing
Partnerships
Patient Support Resources

Expertise Informed by Experience

Sunstone is guided by a team of Clinical Research Coordinators with over 30 years of combined clinical expertise and over 5 years of specialized experience in psychedelic research.

We are currently offering trials to address depression, treatment-resistant depression, postpartum depression, cancer and depression, adjustment disorder, and PTSD. These trials use a variety of psychedelic compounds including, but not limited to psilocybin, MDMA, and 5-MeO-DMT.

Explore Open Studies
  • Adjustment Disorder (AD)
  • Palliative Care
  • Generalized Anxiety Disorde
  • Major Depressive Disorder (MDD)
  • MDD and Cancer
  • Post-Traumatic Stress Disorder 
  • Postpartum Depression
  • Treatment-Resistant Depression
  • Psilocybin 
  • MDMA
  • LSD
  • 5-MeO-DMT
  • Methylone
  • RE-104 (novel serotonergic antidepressant)
  • Beckley Psytech
  • Compass Pathways 
  • Cybin 
  • Lykos Therapeutics
  • MindMed
  • Reunion Neuroscience 
  • Transcend Therapeutics
  • Usona Institute 
  • Adventist HealthCare
  • Dana-Farber Cancer Institute
  • Johns Hopkins Center for Psychedelic &
  • Consciousness Research
  • McGill University 
  • Memorial Sloan Kettering Cancer Center 
  • The University of Vermont 

Participating in a clinical trial at Sunstone contributes to advancing scientific knowledge in the field of mental health research. Sunstone’s clinical team has authored [11] papers on psychedelic research in leading journals, including Cancer, JAMA Oncology, and NIH-Heals. 

View Published Research
Learn More
Our Mission

Our Mission

Sunstone is establishing the gold standard for psychedelic clinics to deliver care that reduces the emotional suffering of those affected by complex mental health challenges and disorders, and to make safe, effective psychedelic-assisted therapy accessible.
Whole Person Healing is